Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy
MOTS-c
Mitochondrial

MOTS-c

Research-Grade

MOTS-c (Mitochondrial Open Reading-frame of the Twelve S ribosomal RNA type-c) is a mitochondrially-encoded peptide identified in 2015. It belongs to the emerging mitokine class — signaling molecules synthesized inside mitochondria that exert systemic effects. Preclinical research has centered on AMPK pathway activation, enhanced skeletal-muscle glucose uptake, improved insulin sensitivity in high-fat-diet rodent models, and extended healthspan in aged mice. MOTS-c expression declines with age in human tissues, paralleling declines in mitochondrial function, and exogenous administration in mice has attenuated age-associated metabolic dysfunction. Human data remains extremely limited; it is classified as a research peptide worldwide.

Specifications

Origin / ManufacturerSynthetic (endogenous homolog)
Active Components
MOTS-c
StorageLyophilized room-temp; reconstituted 2–8°C
Form FactorLyophilized powder vial

Sources & References

Every clinical claim on this page traces to a primary peer-reviewed source.

  1. 1Lee C, Zeng J, Drew BG, et al.. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;21(3):443-54. doi:10.1016/j.cmet.2015.02.009 PMID:25738459
  2. 2Reynolds JC, Lai RW, Woodhead JST, et al.. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. 2021;12:470. doi:10.1038/s41467-020-20790-0 PMID:33473109

Reviewed by

Clinical Research Review Board

Pharmacology & Endocrinology Review

All clinical claims cross-checked against primary sources. Read our editorial policy →

Related Peptides

Reviewed by Clinical Research Review BoardPharmacology & Endocrinology Review

Search

Search across products, blog posts, wiki articles, and more.